Naveen Pemmaraju: Celebrating emerging collaborations across the MD Anderson Cancer Center

Naveen Pemmaraju shared on X:

”Celebrating emerging collaborations across the MD Anderson Cancer Center Cancer Network today with Sumeet Bhatia Community Health Net and Michael Wong.

MD Anderson Cancer Center Melanoma and Naveen Pemmaraju Prof Leukemia and Exec Director for MDACC Cancer Network for Cancer Medicine.”

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.